product image
The Business Cocktail

May 2, 2019

EISAI now solely responsible for lemborexant Eisai today announced that its U.S. subsidiary has bought out  Purdue Pharma L.P.’s rights in the worldwide collaboration fo...

Read More
product image
Can Spinal Muscular Atrophy be treated by Protease Inhibitors?

Apr 24, 2019

Spinal muscular atrophy is a genetic disorder characterised by weakness and wasting (atrophy) of skeletal muscles, used for movement. Loss of specialised nerve cells, calle...

Read More
product image
ColdZyme inactivates viruses; Med for rare genetic disease; Common oral bacteria accelerate Colon cancer; CEPI and CureVac to develop an mRNA vaccine; Celastrol’s effectiveness

Mar 5, 2019

ColdZyme inactivates 99% of viruses causing common cold An Oral spray ColdZyme contains a solution of proteolytic enzyme trypsin and glycerol, which happens to shorten the ...

Read More
product image
Anticoagulants-Market Insights; Drugs Sales Forecast (VTE & AF)

May 10, 2016

According to DelveInsight researchers, the Anticoagulants (VTE & AF) Therapeutics Market was around $11.4 billion in 2015 and is estimated to reach $17.2 billion by 202...

Read More
product image
Fatty Acid Amide Hydrolase (FAAH) Inhibitors – Pipeline Insights, 2015 – A DelveInsight’s Report

Sep 21, 2015

Fatty acid amide hydrolase (FAAH) is an intracellular amidase signature family of serine hydrolases enzyme, which catalyzes the hydrolysis of bioactive fatty acid ethanolam...

Read More